Curemeta Employee Directory

Curemeta corporate office is located in 27 Drydock Ave Ste 28, Boston, Massachusetts, 02210, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

Medical & Health

1

Operations

1

C-Suite

1

Curemeta CEO

MS
United States flag for contact location.
Michael SchopperleChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Curemeta

  • MH
    United States flag for contact location.
    Mats Holmqvist

    Vice President, Operations & Co-Founder

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Curemeta Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from Curemeta

Hundreds of professionals searching for Curemeta have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Curemeta

Explore people who held key positions, contributed to Curemeta's success, and advanced their careers.

  1. Oncology Clinical Deve... at Scientific Strategy

    Worked as Manager of Translational Science

    at Curemeta (2013-2017)

    email Yawen Ju Email direct Yawen Ju Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Curemeta Employees

How many employees does Curemeta have?
Curemeta has 1-10 employees
Who is the CEO of Curemeta?
Curemeta’s CEO is Michael Schopperle
Who are Curemeta key employees?
Some of Curemeta key employees are Mats Holmqvist
Where is Curemeta located?
Curemeta’s headquarters are located at 27 Drydock Ave Ste 28, Boston, Massachusetts, 02210, United States
How do I contact Curemeta?
Curemeta Contact Info: Phone number: (857) 263-8343 Website: www.curemeta.com
What does Curemeta do?

CureMeta is a Boston-based biotech company focused on developing innovative antibodies and Antibody-Drug-Conjugates (ADCs) to target and treat metastatic cancers, particularly pancreatic and gastric cancers. Their lead therapeutic, CM-09, is a humanized antibody that specifically binds to the cancer stem cell marker TRA-1-60, which is present in ag... gressive tumors but absent in healthy tissues. The company aims to transition from preclinical to clinical trials, with plans to initiate a Phase 1 study to evaluate the safety and efficacy of their therapies. CureMeta's mission is to provide effective treatment options for patients suffering from metastatic cancers, addressing a significant unmet medical need.Read More

Is Curemeta a public company?
Curemeta is private company therefore does not currently have an official ticker symbol
See more information about Curemeta Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.